NCT03342014View on ClinicalTrials.gov

First Trimester Screening for Preeclampsia and Intrauterine Growth RestrIction Using Three Dimensional Doppler Angiography

NACompletedINTERVENTIONAL

Enrollment

2,159

Participants

Timeline

Start Date

April 16, 2018

Primary Completion Date

November 14, 2022

Study Completion Date

November 14, 2022

Conditions

Pre-Eclampsia

Interventions

DEVICE

Ultrasound

3DPD and UAD acquisitions (10 min)

BIOLOGICAL

Blood sample collection

A blood sampling (20 mL) is collected for biomarker analysis (PAPP-A and PlGF) and biological collection.

Trial Locations (1)

54500

Centre Hospitalier Régional Universitaire de Nancy, Vandœuvre-lès-Nancy

All Listed Sponsors

lead

Central Hospital, Nancy, France

OTHER

NCT03342014 - First Trimester Screening for Preeclampsia and Intrauterine Growth RestrIction Using Three Dimensional Doppler Angiography | Biotech Hunter | Biotech Hunter